Altered Pharmacokinetics of Statins Explain Increased Risk of Rhabdomyolysis in Advanced Cirrhosis

Gastroenterology. 2016 Nov;151(5):1036. doi: 10.1053/j.gastro.2016.06.055. Epub 2016 Oct 3.

Authors

Rianne A Weersink¹, Joost P H Drenth², Sander D Borgsteede³

Affiliations

¹ Health Base Foundation, Houten, The Netherlands.
² Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands.
³ Health Base Foundation, Houten, The Netherlands and SIR Institute for Pharmacy Practice and Policy, Leiden, The Netherlands.

PMID: 27713044
DOI: 10.1053/j.gastro.2016.06.055

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Drug Interactions
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Liver Cirrhosis
Rhabdomyolysis*
Risk
Simvastatin

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Simvastatin